Treating Recurrent Tricuspid Regurgitation and Iatrogenic Atrial Septal Defect.
JACC Case Rep
; 12: 101775, 2023 Apr 19.
Article
em En
| MEDLINE
| ID: mdl-37091059
ABSTRACT
Heterotopic caval valve implantation may be a reasonable option for alleviating symptoms in select high-risk patients with recurrent tricuspid regurgitation after failed interventional tricuspid valve repair. However, altered right atrial hemodynamic status should be considered in procedural planning to avoid potential right-left shunting in cases of septal defects. (Level of Difficulty Advanced.).
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article